BeiGene, Ltd. - American Depositary Shares (NQ: ONC )

222.91 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	222.91
Bid (Size)	225.78 (1)
Ask (Size)	245.00 (1)
Prev. Close	222.91
Today's Range	222.91 - 222.91
52wk Range	172.67 - 229.75
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ImmunityBio Stock Soars On BeiGene Tie-Up, Supply Deal: Retail Gets Dose Of Optimism

January 29, 2025

The study will evaluate a combination therapy using BeiGene’s tislelizumab and ImmunityBio’s Anktiva for certain patients with advanced or metastatic non-small cell lung cancer

Via Stocktwits

Leap Therapeutics Halts Sirexatamab Combo Therapy For Gastric Cancer ON Unclear Positive Signal, Stock Crashes

January 28, 2025

Leap Therapeutics' Phase 2 data shows sirexatamab improves ORR in colorectal cancer. Gastric cancer studies end due to lack of PFS benefit.

Via Benzinga

Performance

YTD	+21.15%	+21.15%
1 Month	+23.40%	+23.40%
3 Month	+21.15%	+21.15%
6 Month	+21.15%	+21.15%
1 Year	+21.15%	+21.15%

More News

MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

January 19, 2025

Via Benzinga

BeiGene Stock Meets 80-Plus RS Rating Benchmark

January 15, 2025

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session

January 14, 2025

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.